Amundi Raises Position in GE HealthCare Technologies Inc. $GEHC

Amundi lifted its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 129.9% during the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 2,500,094 shares of the company's stock after purchasing an additional 1,412,453 shares during the quarter. Amundi owned about 0.55% of GE HealthCare Technologies worth $160,031,000 as of its most recent SEC filing.

Several other hedge funds have also modified their holdings of GEHC. NBH Bank acquired a new stake in GE HealthCare Technologies during the 2nd quarter worth approximately $26,000. Godfrey Financial Associates Inc. acquired a new position in GE HealthCare Technologies in the fourth quarter worth about $27,000. Transamerica Financial Advisors LLC increased its holdings in GE HealthCare Technologies by 331.6% in the fourth quarter. Transamerica Financial Advisors LLC now owns 341 shares of the company's stock valued at $28,000 after buying an additional 262 shares during the last quarter. Physician Wealth Advisors Inc. increased its holdings in GE HealthCare Technologies by 60.4% in the first quarter. Physician Wealth Advisors Inc. now owns 433 shares of the company's stock valued at $31,000 after buying an additional 163 shares during the last quarter. Finally, MV Capital Management Inc. acquired a new stake in GE HealthCare Technologies during the fourth quarter valued at approximately $33,000. 82.06% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

GEHC has been the subject of a number of research reports. BMO Capital Markets initiated coverage on shares of GE HealthCare Technologies in a report on Wednesday, July 8th. They issued a "market perform" rating and a $70.00 price objective for the company. Wells Fargo & Company boosted their price objective on shares of GE HealthCare Technologies from $75.00 to $85.00 and gave the company an "overweight" rating in a research report on Thursday, July 30th. Weiss Ratings reiterated a "hold (c-)" rating on shares of GE HealthCare Technologies in a research note on Wednesday, August 12th. Hovde Group assumed coverage on shares of GE HealthCare Technologies in a report on Friday, July 17th. They issued a "market perform" rating and a $14.00 target price on the stock. Finally, Royal Bank Of Canada assumed coverage on shares of GE HealthCare Technologies in a report on Tuesday, June 23rd. They issued an "outperform" rating and a $80.00 price objective on the stock. Ten analysts have rated the stock with a Buy rating and eleven have assigned a Hold rating to the stock. Based on data from MarketBeat, GE HealthCare Technologies currently has a consensus rating of "Hold" and an average target price of $77.73.

GE HealthCare Technologies Stock Performance

Shares of GEHC opened at $66.78 on Wednesday. The firm has a market capitalization of $30.16 billion, a PE ratio of 15.32, a P/E/G ratio of 1.82 and a beta of 0.70. The company has a quick ratio of 0.97, a current ratio of 1.26 and a debt-to-equity ratio of 0.92. The firm has a 50-day moving average price of $68.42 and a 200 day moving average price of $68.72. GE HealthCare Technologies Inc. has a 52-week low of $58.75 and a 52-week high of $89.77.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last released its quarterly earnings results on Wednesday, July 29th. The company reported $1.13 EPS for the quarter, topping analysts' consensus estimates of $1.04 by $0.09. The company had revenue of $5.29 billion for the quarter, compared to the consensus estimate of $5.26 billion. GE HealthCare Technologies had a net margin of 9.33% and a return on equity of 20.12%. GE HealthCare Technologies's revenue was up 5.8% on a year-over-year basis. During the same period in the previous year, the firm earned $1.06 EPS. On average, sell-side analysts anticipate that GE HealthCare Technologies Inc. will post 4.93 earnings per share for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, August 14th. Shareholders of record on Friday, July 24th were given a $0.035 dividend. This represents a $0.14 dividend on an annualized basis and a yield of 0.2%. The ex-dividend date was Friday, July 24th. GE HealthCare Technologies's dividend payout ratio is 3.21%.

GE HealthCare Technologies Profile

GE HealthCare Technologies NASDAQ: GEHC is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.